Defining genomic mechanisms associated with treatment response, drug resistance and early blast crisis in chronic myeloid leukaemia [ 2017 - ]

Research Grant

Researchers: A/Pr Susan Branford (Principal investigator)

Brief description Chronic myeloid leukaemia is a fatal disease if untreated. Most patients now survive with new drugs, but some still rapidly die. I aim to understand these differences by investigating the genetic makeup of patients at diagnosis. Some may have gene mutations that prevent drugs from working effectively. Mutations will be detected using technology that can search more than 30,000 genes at the same time. This work could lead to improved survival for more patients by finding new targets for therapy.

Funding Amount $631,370.00

Funding Scheme Research Fellowships

Notes Research Fellowship